Pharmaceutical and medical products supplier Cardinal Health Inc. (NYSE: CAH) has sold the remaining stake in its spinoff medical technology company for $706 million.
Cardinal sold 30.5 million shares, which represents about 14 percent of CareFusion Corp.’s (NYSE: CFN) outstanding shares, in a block trade to Morgan Stanley.
Based on the numbers in Cardinal’s regulatory filing that announced the sale, the Dublin, Ohio, company gave Morgan Stanley a discount for taking the shares off its hands. The sale price comes out to about $23.14 a share. But CareFusion closed at $24 the day prior to the Sept. 15 sale.
Top 7 Modern AI-Powered EAP Providers for Global Workforces in 2026
Discover the top AI-powered EAP providers for 2026. Compare platforms like Kyan Health and Spring Health on triage speed, global reach, and clinical quality to transform workforce wellbeing.
“It’s not uncommon to see a discount on a large block trade like this,” Troy Kilpatrick, a Cardinal spokesman, said.
Cardinal spun off San Diego-based CareFusion about a year ago to focus more intensely on its supply chain business. At the time, Cardinal retained about 19 percent of CareFusion’s shares, selling 10.9 million shares for $270 million in the fiscal year ended June 30.
Kilpatrick said the spinoff deal with CareFusion required Cardinal to unload all of its shares in the San Diego company within 5 years. Cardinal sold the shares because market conditions were right for it to find a buyer, he said.
CareFusion makes drug-delivery systems and infection-prevention tools. Last month, the San Diego spinoff said it would lay off about 5 percent of its workforce — 700 employees — due to declining profits.
The Healthcare Payments Industry Has a Perception Problem
Healthcare payments are no longer about transactions. It’s about controlling the revenue cycle. And increasingly, that control is not sitting with ISOs.